Neuroprotective effects of resveratrol

Resveratrol in Health and Disease

Volumn , Issue , 2005, Pages 619-630

  Han, Ying Shan ^a   Bastianetto, Stéphane ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951850049     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420026474     Document Type: Chapter

References (47)

1. Bavaresco L, Fregoni C, Cantu E, and Trevisan M, Stilbene compounds: from the grapevine to wine, Drugs Exp Clin Res 25, 57-63, 1999.
2. Bhat KPL, Kosmeder JW, and Pezzuto JM, Biological effects of resveratrol, Antioxid Redox Signal 3, 1041-1064, 2001.
3. Goldberg DM, Hahn SE, and Parkes JG, Beyond alcohol: beverage consumption and cardiovascular mortality, Clin Chim Acta 237, 155-187, 1995.
4. Leibovici D, Ritchie K, Ledesert B, and Touchon J, The effects of wine and tobacco consumption on cognitive performance in the elderly: a longitudinal study of relative risk, Int J Epidemiol 28, 77-81, 1999.
5. Lemeshow S, Letenneur L, Dartigues JF, Lafont S, Orgogozo JM, and Commenges D, Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid, Am J Epidemiol 148, 298-306, 1998.
6. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, and Breteler MB, Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area, Rev Neurol 153, 185-192, 1997.
7. Chanvitayapongs S, Draczynska-Lusiak B, and Sun AY, Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells, Neuroreport 8, 1499-1502, 1997.
8. Draczynska-Lusiak B, Chen YM, and Sun AY, Oxidized lipoproteins activate NF-kappaB binding activity and apoptosis in PC12 cells, Neuroreport 9, 527-532, 1998.
9. Frankel D and Schipper HM, Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury, Exp Neurol 160, 376-385, 1999.
10. Bastianetto S, Zheng WH, and Quirion R, Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons, Br J Pharmacol 131, 711-720, 2000.
11. Bastianetto S and Quirion R, Natural extracts as possible protective agents of brain aging, Neurobiol Aging 23, 891-897, 2002.
12. Jang JH and Surh YJ, Protective effects of resveratrol on hydrogen peroxideinduced apoptosis in rat pheochromocytoma (PC12) cells, Mutation Res 496, 181-190, 2001.
13. Conte A, Pellegrini S, and Tagliazucchi D, Effect of resveratrol and catechin on PC12 tyrosine kinase activities and their synergistic protection from betaamyloid toxicity, Drugs Exp Clin Res 29, 243-255, 2003.
14. Jang JH and Surh YJ, Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death, Free Radical Biol Med 34, 1100-1110, 2003.
15. Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, and Muller-Spahn F, Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity, Gerontology 49, 380-383, 2003.
16. Han YS, Zheng WH, Bastianetto S, Chabot JG, and Quirion R, Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C, Br J Pharmacol 141, 997-1005, 2004.
17. Araki T, Sasaki Y, and Milbrandt J, Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration, Science 305, 1010-1013, 2004.
18. Huang SS, Tsai MC, Chih CL, Hung LM, and Tsai SK, Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia, Life Sci 69, 1057-1065, 2001.
19. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, and Sun AY, Resveratrol protects against global cerebral ischemic injury in gerbils, Brain Res 958, 439-447, 2002.
20. Sinha K, Chaudhary G, and Gupta YK, Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats, Life Sci 71, 655-665, 2002.
21. Inoue H, Jiang XF, Katayama T, Osada S, Umesono K, and Namura S, Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice, Neurosci Lett 352, 203-206, 2003.
22. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, and Goldberg DM, Wines and grape juices as modulators of platelet aggregation in healthy human subjects, Clin Chim Acta 246, 163-182, 1996.
23. Bastianetto S and Quirion R, Resveratrol and red wine constituents: evaluation of their neuroprotective properties, Pharm. News 8, 33-38, 2001.
24. Sun AY, Simonyi A, and Sun GY, The “French Paradox” and beyond:neuroprotective effects of polyphenols, Free Radical Biol Med 32, 314-318, 2002.
25. Russo A, Palumbo M, Aliano C, Lempereur L, Scoto G, and Renis M, Red wine micronutrients as protective agents in Alzheimer-like induced insult, Life Sci 72, 2369-2379, 2003.
26. Miloso M, Bertelli AA, Nicolini G, and Tredici G, Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells, Neurosci Lett 264, 141-144, 1999.
27. Tredici G, Miloso M, Nicolini G, Galbiati S, Cavaletti G, and Bertelli A, Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant?, Drugs Exp Clin Res 25, 99-103, 1999.
28. Zhuang H, Kim YS, Koehler RC, and Dore S, Potential mechanism by which resveratrol, a red wine constituent, protects neurons, Ann NY Acad Sci 993, 276-286, 2003.
29. Sun AY, Chen YM, James-Kracke M, Wixom P, and Cheng Y, Ethanolinduced cell death by lipid peroxidation in PC12 cells, Neurochem Res 22, 1187-1192, 1997.
30. Gelinas S and Martinoli MG, Neuroprotective effect of estradiol and phytoestrogens on MPPþ-induced cytotoxicity in neuronal PC12 cells, J Neurosci Res 70, 90-96, 2002.
31. Moosmann B and Behl C, The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties, Proc Natl Acad Sci USA 96, 8867-8872, 1999.
32. Nicolini G, Rigolio R, Scuteri A, Miloso M, Saccomanno D, Cavaletti G, and Tredici G, Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells, Neurochem Int 42, 419-429, 2003.
33. Karlsson J, Emgard M, Brundin P, and Burkitt MJ, Trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism, J Neurochem 75, 141-150, 2000.
34. De Ruvo C, Amodio R, Algeri S, Martelli N, Intilangelo A, D’Ancona GM, and Esposito E, Nutritional antioxidants as antidegenerative agents, Int J Dev Neurosci 18, 359-366, 2000.
35. Virgili M and Contestabile A, Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats, Neurosci Lett 281, 123-126, 2000.
36. Sharma M and Gupta YK, Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats, Life Sci 71, 2489-2498, 2002.
37. Kiziltepe U, Turan NN, Han U, Ulus AT, and Akar F, Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury, J Vasc Surg 40, 138-145, 2004.
38. Sovak M, Grape extract, resveratrol, and its analogs: a review, J Med Food 4, 93-105, 2001.
39. Andrabi SA, Spina MG, Lorenz P, Ebmeyer U, Wolf G, and Horn TF, Oxyresveratrol (trans-2,30,4,50-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia, Brain Res 1017, 98-107, 2004.
40. Green PS, Gordon K, and Simpkins JW, Phenolic A ring requirement for the neuroprotective effects of steroids, J Steroid Biochem Mol Biol 63, 229-235, 1997.
41. Han Y, Dumont Y, and Quirion R, On a Possible Novel Mechanism of Action for Resveratrol, Program No. 219.9, abstract, Society for Neuroscience’s 34th Annual Meeting, San Diego, Oct. 23-27, 2004.
42. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, and Kowall N, Oxidative damage in Alzheimer’s, Nature 382, 120-121, 1996.
43. Miller NJ and Rice-Evans CA, Antioxidant activity of resveratrol in red wine, Clin Chem 41, 1789, 1995.
44. Belguendouz L, Fremont L, and Linard A, Resveratrol inhibits metal iondependent and independent peroxidation of porcine low-density lipoproteins, Biochem Pharmacol 53, 1347-1355, 1997.
45. Della Ragione F, Cucciolla V, Criniti V, Indaco S, Borriello A, and Zappia V, Antioxidants induce different phenotypes by a distinct modulation of signal transduction, FEBS Lett 532, 289-294, 2002.
46. Martindale JL and Holbrook NJ, Cellular response to oxidative stress:signaling for suicide and survival, J Cell Physiol 192, 1-15, 2002.
47. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, and Dannenberg AJ, Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells, J Biol Chem 273, 21875-21882, 1998.